Skip to main content
Clinical Trials/TCTR20160715004
TCTR20160715004Completed未知

Efficacy of intravenous 100 mcg carbetocin versus intravenous 5 units oxytocin for prevention of immediate postpartum hemorrhage after normal vagina delivery among high risk prenancies; a tripple-blinded randomized controlled trial

Siriraj Routine to Research Unit0 sites350 target enrollmentStarted: July 15, 2016Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
350

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 Years to 50 Years (—)
Sex
Female

Inclusion Criteria

  • 1. Thai pregnant woman
  • 2. age at least 20 years old
  • 3. Pregnancy age at least 34 weeks gestation
  • 4. normal vaginal delvery
  • 5. high risk for PPH including previous history of PPH, induction or augmentation of labour, tocolytic drug before delivery, prolonged active phase of labour, precipitate labour, grand multipara, overdistended uterus, uterine structural abnormality

Exclusion Criteria

  • 1. being active labour
  • 2. Contraindication to carbetocin
  • 3. allergy to oxytocin or carbetocin
  • 4. obstetrics complication including preeclampsia and abnormal placentation

Investigators

Sponsor
Siriraj Routine to Research Unit

Similar Trials